Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (317)	3/15/2004 9:15:04 AM
From: Icebrg	Read Replies (1) \| Respond to of 590

ADVISORY/Abgenix Scales Up! Monday March 15, 9:02 am ET Abgenix to Hold Private Job Fair to Recruit for Large Number of Jobs in Manufacturing and Quality Who: Abgenix, a Fremont-based biopharmaceutical company, is hosting one of the largest local job fairs to date for biotechnology manufacturing and quality. President and CEO Raymond Withy, Ph.D., will be available for photographs and interviews, along with Fremont Mayor Gus Morrison, who will attend the event on behalf of the City of Fremont. What: Abgenix is holding a job fair for its new, state-of-the-art, 100,000-square foot biologics manufacturing facility, which recently received a California Construction "Best of 2003" award. Abgenix plans to increase its workforce at the site by more than 20% and is looking for talented candidates to fill dozens of positions in manufacturing, quality assurance, quality control, and other areas. Abgenix currently employs approximately 400 workers in Fremont. Where: Abgenix Corporate Headquarters, 6701 Kaiser Drive, Fremont, Calif. When: Saturday, March 27, 2004, 1:00-4:00 pm Why: "Abgenix has assembled the specialized facilities and has developed the expertise required to produce human therapeutic antibodies on both a clinical and commercial scale. Now we need the best, most experienced people to help us produce the therapies of the future," says Raymond M. Withy, Ph.D., president and CEO of Abgenix.